EUVIMEDEUVIMED entdecken
CrossrefInfokarte

A real‐world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits

Michal Kori, Anat Guz‐Mark, Tsachi Tsadok Perets, Amit Davidpur, Assaf Hoofien, Raanan Shamir

JPGN Reports · 2026-11-09

DOI: 10.1002/jpr3.70287 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objectives Pediatric celiac disease (CeD) may be diagnosed without a biopsy when tissue‐transglutaminase (TTG) immunoglobulin A (IgA) antibodies are ≥10x the upper limit of normal (ULN) and anti‐endomysial antibodies are positive in a second sample. The no‐biopsy diagnosis demands a very high accuracy and reliability of the TTG diagnostic kits. Inter‐assay differences may affect category classification. We compared TTG‐IgA levels performed by two reliable kits: Bioplex 2200 and Liaison‐XL in routine care. Methods Using the Clalit Health Services database, we identified pediatric patients with paired TTG‐IgA measurements from both kits within ≤14 days. Values were expressed as multiples of ULN and categorized: 10x ULN. Agreement was assessed for ≤7 and ≤14‐day windows using Cohen's ĸ . Results Category discordance occurred in 17.4% (109/625) of paired tests within 14 days and 11.8% (38/321) within 7 days. Overall agreement was substantial ( ĸ = 0.62 for 14 days; ĸ = 0.63 for 7 days). Concordance was high for negative results (96.0%), but significantly lower for the critical >10x ULN threshold at 14 days (88.2%, p = 0.009). Conclusions Significant discordance between these two reliable TTG‐IgA kits at 14 days, exceeding 10% in the >10x ULN category, warrants careful consideration when using the no‐biopsy approach for CeD diagnosis, as assay choice may impact clinical classification.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →